URB597 Changed Morphine Tolerance and Passive-Avoidance Learning in Rats
A rat study found that URB597 prevented the tested development of morphine antinociceptive tolerance and alleviated morphine-related impairment on a passive-avoidance learning task. These were two separately measured outcomes of an endocannabinoid-enzyme intervention.
Repeated morphine established the adaptation question
The investigators administered morphine repeatedly and gave URB597 beforehand. Tolerance was assessed with a tail-flick test. Morphine alone showed significant tolerance on later treatment days, whereas URB597 prevented that development in the reported procedure. Pretreatment during repeated exposure differs from demonstrating reversal after tolerance has already become established.
The cognition finding came from a specific task
Passive avoidance assessed learning under the experiment's conditions. URB597 enhanced acquisition and alleviated the impairment associated with morphine. That result is narrower than a claim of comprehensive cognitive restoration. It did not assess every memory process, complex judgment or driving performance.
FAAH inhibition is not interchangeable with cannabis exposure
URB597 inhibits a metabolic enzyme involved in endocannabinoid signaling. Altering endogenous lipid handling differs from administering THC or a cannabis extract. The study therefore cannot establish that cannabis prevents opioid-related cognitive problems. The abstract's favorable characterization of the inhibitor also does not independently establish clinical safety or absence of abuse potential in all settings.
Interpreting the evidence
The study connects two rat endpoints under a defined pretreatment regimen. Human efficacy, safety and the persistence of benefit require separate evidence; they cannot be inferred solely from improved tail-flick and learning performance.
Related reading: endogenous ligands administered as experimental drugs.
Research reference
Hasanein P; Ghafari-Vahed M (2016). Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats. Behavioural pharmacology. doi:10.1097/FBP.0000000000000179. Evidence basis: study abstract.
